News

Public · Published

Medicus Pharma to Present at BioFuture and Global Biotechnology Summit

Medicus Pharma said its Executive Chairman and CEO, Dr. Raza Bokhari, will present at BioFuture 2026 in New York City on Oct. 27 and deliver a keynote at the Global Biotechnology Summit 2026 in Abu Dhabi, highlighting progress on targeted cancer therapeutics.

Published:

Updated:

What happened

Medicus Pharma said its Executive Chairman and CEO, Dr. Raza Bokhari, will present at BioFuture 2026 in New York City on Oct. 27 and deliver a keynote at the Global Biotechnology Summit 2026 in Abu Dhabi, highlighting progress on targeted cancer therapeutics.

Confirmed

Global impact / market context

Conference presentations give a small biotech company a chance to attract partners, investors and clinicians without a paid advertising campaign. Greater visibility for its two investigational products could support future fundraising or collaboration talks, though no deal or financial commitment was announced.

Analyst inference

Investors in early-stage drug developers often track conference appearances for updates on experimental treatments, because clinical progress is the main driver of value before products reach the market. These events can shape how the company is positioned against other cancer-therapy developers.

Analyst inference

What to watch

  1. The BioFuture 2026 presentation is scheduled for Oct. 27, 2026, from 2:00 to 2:55 p.m. Eastern Time, with Dr. Bokhari on Spotlight Panel 3A about revolutionary cancer therapeutics. Confirmed
  2. Watch whether the company discloses new data or timelines for CD228V, an investigational antibody-drug conjugate, which means a lab-made molecule designed to deliver treatment directly to cancer cells. Proposed
  3. Any partnering or financing discussions sparked by these appearances could affect the company's cash available and its ability to fund capital spending on the two investigational products. Analyst inference

Evidence